Abstract
Malaria remains a major public health concern. Particularly in Nigeria where more than 80% of the cases are reported and locally among natives in Nigeria. There are serious indication of insecticide resistance in Nigeria. Under PMI/Vectorlink laboratory condition, cement plaster surface and wooden board were brushed with a primer within 24-48hours before the paint application. The inesfly vesta 50 (transfluthrin 0.5% w/w) insecticide paint was applied at the dosage of 8m2/L for cement and wooden board drying at room temperature for 5 days. The plastic cones were fixed on the treated walls and wooden board at 0.5m, 1.0m, and 1.5m parameters height, after which 10 non-blood fed females mosquito were gently introduced into the cone chamber for 30- 60 minutes observation. The holding paper cups were kept under favourable temperature of 27oc and humidity at 70%. In a dose trial finding, the data obtained were analyzed in IBM SPSS version 23.0 using ANOVA and the results presented as mean ± standard deviations of triplicate observations showed 100% yield (100.0±0.00*) mortality of malaria vector of novel trial with 0.5% w/w transfluthrin painted substrates in 24hours post exposure to 6months post application, except that, at l.5m in the month of July, 98% knockdown/mortality was recorded which follow same sequence of method and procedure in the application on the substrate absorbency, though, results showed high level of susceptibility from February to July (100% mortality rate). Results from wall cone and wooden board bio-assay residuality was alarming, with very high kill rates observed after 24hours post exposure. From the treated bio-assay of inesfly vesta 50 (Transfluthrin 0.5% w/w) by possible means showed that, this formulation is effective on malaria vector and possibly other insects. This suggests that, the transfluthrin 0.5% w/w can be tried alongside other known application with organophosphate, pyrethroids and the carbamate group, and can reduce human mosquito contact and impact on the perennial malaria transmission.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.